Increasing Age Predicts Poor Cervical Cancer Prognosis with Subsequent Effect on Treatment and Overall Survival

Por Quinn, Bridget A., Deng, Xiaoyan, Colton, Adrianne, Bandyopadhyay, Dipankar, Carter, Jori, Fields, Emma C.
Publicado no Brachytherapy (2018)

Development of a syngeneic mouse model of epithelial ovarian cancer

Por Quinn, Bridget A, Xiao, Fang, Bickel, Laura, Martin, Lainie, Hua, Xiang, Klein-Szanto, Andres, Connolly, Denise C
Publicado em 2010

Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53

Por Quinn, Bridget A., Brake, Tiffany, Hua, Xiang, Baxter-Jones, Kimberly, Litwin, Samuel, Ellenson, Lora Hedrick, Connolly, Denise C.
Publicado em 2009

Reversing Translational Suppression and Induction of Toxicity in Pancreatic Cancer Cells Using a Chemoprevention Gene Therapy Approach

Por Sarkar, Siddik, Quinn, Bridget A., Shen, Xuening, Dent, Paul, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, Fisher, Paul B.
Publicado no Mol Pharmacol (2015)

Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid

Por Bhoopathi, Praveen, Quinn, Bridget A., Gui, Qin, Shen, Xue-Ning, Grossman, Steven R., Das, Swadesh K., Sarkar, Devanand, Fisher, Paul B., Emdad, Luni
Publicado em 2014

Mcl-1 is an important therapeutic target for oral squamous cell carcinomas

Por Maji, Santanu, Samal, Sabindra K, Pattanaik, Laxmipriya, Panda, Swagatika, Quinn, Bridget A., Das, Swadesh K., Sarkar, Devanand, Pellecchia, Maurizio, Fisher, Paul B., Dash, Rupesh
Publicado no Oncotarget (2015)

Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline

Por Quinn, Bridget A., Dash, Rupesh, Sarkar, Siddik, Azab, Belal, Bhoopathi, Praveen, Das, Swadesh K., Emdad, Luni, Wei, Jun, Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Publicado no Cancer Res (2015)

Design and characterization of novel EphA2 agonists for targeted delivery of chemotherapy to cancer cells

Por Wu, Bainan, Wang, Si, De, Surya K., Barile, Elisa, Quinn, Bridget A., Zharkikh, Irina, Purves, Angela, Stebbins, John L., Oshima, Robert G., Fisher, Paul B., Pellecchia, Maurizio
Publicado no Chem Biol (2015)

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic

Por Sarkar, Siddik, Quinn, Bridget A., Shen, Xue-Ning, Dash, Rupesh, Das, Swadesh K., Emdad, Luni, Klibanov, Alexander L., Wang, Xiang-Yang, Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Publicado no Oncotarget (2015)

Targeting the Bcl-2 Family for Cancer Therapy

Por Thomas, Shibu, Quinn, Bridget A., Das, Swadesh K., Dash, Rupesh, Emdad, Luni, Dasgupta, Santanu, Wang, Xiang-Yang, Dent, Paul, Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Publicado em 2012

Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

Por Quinn, Bridget A., Wang, Si, Barile, Elisa, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, De, Surya K., Kharagh, Susan Morvaridi, Stebbins, John L., Pandol, Stephen J., Fisher, Paul B., Pellecchia, Maurizio
Publicado no Oncotarget (2016)

Enhanced Prostate Cancer Gene Transfer and Therapy Using a Novel Serotype Chimera Cancer Terminator Virus (Ad.5/3-CTV)

Por AZAB, BELAL M., DASH, RUPESH, DAS, SWADESH K., BHUTIA, SUJIT K., SARKAR, SIDDIK, SHEN, XUE-NING, QUINN, BRIDGET A., DENT, PAUL, DMITRIEV, IGOR P., WANG, XIANG-YANG, CURIEL, DAVID T., PELLECCHIA, MAURIZIO, REED, JOHN C., SARKAR, DEVANAND, FISHER, PAUL B.
Publicado no J Cell Physiol (2014)

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in...

Por Azab, Belal, Dash, Rupesh, Das, Swadesh K., Bhutia, Sujit K., Shen, Xue-Ning, Quinn, Bridget A., Sarkar, Siddik, Wang, Xiang-Yang, Hedvat, Michael, Dmitriev, Igor P., Curiel, David T., Grant, Steven, Dent, Paul, Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Publicado em 2012

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24–mediated toxicity

Por Dash, Rupesh, Azab, Belal, Quinn, Bridget A., Shen, Xuening, Wang, Xiang-Yang, Das, Swadesh K., Rahmani, Mohamed, Wei, Jun, Hedvat, Michael, Dent, Paul, Dmitriev, Igor P., Curiel, David T., Grant, Steven, Wu, Bainan, Stebbins, John L., Pellecchia, Maurizio, Reed, John C., Sarkar, Devanand, Fisher, Paul B.
Publicado em 2011

Targeting Mcl-1 for the therapy of cancer

Por Quinn, Bridget A., Dash, Rupesh, Azab, Belal, Sarkar, Siddik, Das, Swadesh K., Kumar, Sachin, Oyesanya, Regina A., Dasgupta, Santanu, Dent, Paul, Grant, Steven, Rahmani, Mohamed, Curiel, David T., Dmitriev, Igor, Hedvat, Michael, Wei, Jun, Wu, Bainan, Stebbins, John L., Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Publicado em 2011

mda-7/IL-24: A Unique Member of the IL-10 Gene Family Promoting Cancer-Targeted Toxicity

Por Dash, Rupesh, Bhutia, Sujit K., Azab, Belal, Su, Zhao-zhong, Quinn, Bridget A., Kegelmen, Timothy P., Das, Swadesh K., Kim, Keetae, Lee, Seok-Geun, Park, Margaret A., Yacoub, Adly, Rahmani, Mohammed, Emdad, Luni, Dmitriev, Igor P., Wang, Xiang-Yang, Sarkar, Devanand, Grant, Steven, Dent, Paul, Curiel, David T., Fisher, Paul B.
Publicado em 2010

Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules

Por Hedvat, Michael, Emdad, Luni, Das, Swadesh K., Kim, Keetae, Dasgupta, Santanu, Thomas, Shibu, Hu, Bin, Zhu, Shan, Dash, Rupesh, Quinn, Bridget A., Oyesanya, Regina A., Kegelman, Timothy P., Sokhi, Upneet K., Sarkar, Siddik, Erdogan, Eda, Menezes, Mitchell E., Bhoopathi, Praveen, Wang, Xiang-Yang, Pomper, Martin G., Wei, Jun, Wu, Bainan, Stebbins, John L., Diaz, Paul W., Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Publicado em 2012